Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?-Reference-Cited by-同舟云学术

Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?

Published:2007-08 Issue:11 Volume:8 Page:1615-1628
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

McIntyre Roger S,Soczynska Joanna K,Woldeyohannes Hanna O,Lewis Gary F,Leiter Lawrence A,MacQueen Glenda M,Miranda Andrew,Fulgosi Don,Konarski Jakub Z,Kennedy Sidney H

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.8.11.1615

Reference125 articles.

1. The epidemiology of DSM-III-R bipolar I disorder in a general population survey

2. KESSLER R: Comorbidity of unipolar and bipolar depression with other psychiatric disorders in a general population survey. (1999):1-25.

3. Neurocognitive impairment in drug-free patients with major depressive disorder

4. Cognitive deficits are associated with functional impairment in severely depressed patients

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type 2 diabetes mellitus-associated cognitive dysfunction: Advances in potential mechanisms and therapies;Neuroscience & Biobehavioral Reviews;2022-06

2. PPARγ-Induced Global H3K27 Acetylation Maintains Osteo/Cementogenic Abilities of Periodontal Ligament Fibroblasts;International Journal of Molecular Sciences;2021-08-11

3. Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders;Frontiers in Pharmacology;2021-05-24

4. Neuromodulatory effects of anti-diabetes medications: A mechanistic review;Pharmacological Research;2020-02

5. IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2018-01